| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388075 Medicament containing activated antithrombin III |
| 06/17/2008 | US7388070 inhibitors of DNA polymerase and DNA repair enzymes for treating viral infections, bacterial infections, fungal infections, protozoan infections, and neoplastic diseases; herpes viruses, herpes simplex virus (HSV), and human cytomegalovirus (CMV); peptidomimetics that mimic helical portions of proteins |
| 06/17/2008 | US7388002 Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/17/2008 | US7387773 Vaccine |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2384188C Antiviral compositions |
| 06/17/2008 | CA2331076C Stable carbanilide composition |
| 06/17/2008 | CA2309963C 6-o-alkyl erythromycin b oxime |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2177667C Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant |
| 06/17/2008 | CA2166388C Antifungal composition for external use retentive in stratum corneum |
| 06/17/2008 | CA2151826C Pharmaceutical compositions for prevention and treatment of cancerous diseases and process for their preparation |
| 06/17/2008 | CA1341574C Plasmid for production of membrane protein, bacterium containing same, monoclonal antibody therefore, and method for the idenification of haemophilus influenzae |
| 06/12/2008 | WO2008070733A2 Macrocyclic hepatitis c serine protease inhibitors and uses therefor |
| 06/12/2008 | WO2008070619A1 Deuterated oxazolidinones and their use as antibiotics |
| 06/12/2008 | WO2008070347A2 Betulin-peptide conjugates |
| 06/12/2008 | WO2008070332A2 Feline influenza vaccine and method of use |
| 06/12/2008 | WO2008069619A1 Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same |
| 06/12/2008 | WO2008069349A1 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors |
| 06/12/2008 | WO2008069290A1 Anti-hiv drug comprising fusion protein containing multimeric actinohivin, polypeptide constituting the same, gene encoding the polypeptide and method for producing the anti-hiv drug |
| 06/12/2008 | WO2008069168A1 Method for production of 2-hydroxymethylpyrrolidin-3,4-diol or intermediate thereof |
| 06/12/2008 | WO2008069069A1 Amide compound and salt thereof, and biofilm formation inhibitor or biofilm remover using the same |
| 06/12/2008 | WO2008068765A2 Compositions and methods for inhibiting hiv-1 replication and integrase activity |
| 06/12/2008 | WO2008068470A1 Antibacterial polycyclic urea compounds |
| 06/12/2008 | WO2008068393A1 Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses |
| 06/12/2008 | WO2008068270A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068269A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068268A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068267A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068266A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068231A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 06/12/2008 | WO2008068127A1 Thuggacin-type macrolide antibiotics and their use as antimycobacterial agents |
| 06/12/2008 | WO2008068037A1 Cholesterylamines for the treatment and prevention of infectious diseases |
| 06/12/2008 | WO2008067982A2 Use of carrageenan for treating rhinovirus infections |
| 06/12/2008 | WO2008067774A1 An antimycotic pharmaceutical composition |
| 06/12/2008 | WO2008067644A1 Inhibitors of hiv replication |
| 06/12/2008 | WO2008046796A3 Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections |
| 06/12/2008 | WO2008038175A3 Dithiolopyrrolones compounds and their therapeutic applications |
| 06/12/2008 | WO2008033389A3 Macrocyclic hcv inhibitors and their uses |
| 06/12/2008 | WO2007081597A3 Peri condensed tricyclic compounds useful as antibacterial agents |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080140036 Antimicrobial Composition |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139673 Screening using histone deacetylase mutant fungal strains; precise targets and mechanisms of synergy |
| 06/12/2008 | US20080139626 Novel Method |
| 06/12/2008 | US20080139596 Modulators of Hcv Replication |
| 06/12/2008 | US20080139594 e.g. 4-[8-Chloro-2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]-n-phenylpyrimidin-2-amine; synthesis |
| 06/12/2008 | US20080139583 Phosphodiesterase 4 inhibitors |
| 06/12/2008 | US20080139579 Hiv Integrase Inhibitors |
| 06/12/2008 | US20080139577 Nitroheteroaryl-containing rifamycin derivatives |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139574 Novel quinoline derivatives |
| 06/12/2008 | US20080139572 Diketo-piperazine and piperidine derivatives as antiviral agents |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139563 Oxazolidinone derivatives and methods of use |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139545 Non-aminoglycoside antibiotic such as a quinolone antibiotic, ciprofloxacin or ofloxacin; antiinflammatory agent such as dexamethasone; and a biofilm-dissolving agent; otitis; cleaning contact lenses or surgical and dental equipment |
| 06/12/2008 | US20080139540 Antibacterial Agents |
| 06/12/2008 | US20080139539 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 06/12/2008 | US20080139536 Benzodiazepines for Treating or Preventing Rsv Infection |
| 06/12/2008 | US20080139528 Cefdinir oral suspension |
| 06/12/2008 | US20080139526 Modified release dosage forms of amoxicillin |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139496 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections |
| 06/12/2008 | US20080139495 Synergistic mixture of dipyrido[2,3-b; 3,2f][1-4]diaxepines and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, or guanosine type derivatives; human retrovirus (HRV), hepatitis B virus (HBV), human T-cell leukemia/lymphoma virus, AIDS |
| 06/12/2008 | US20080139468 Method For Control of Invasion and Use of Adiponectin |
| 06/12/2008 | US20080139450 Antimicrobial Compositions and Uses Thereof |
| 06/12/2008 | US20080138894 Recombinant expression in eukaryotic or mammalian cells using vectors; cleavage and site-directed mutagenesis |
| 06/12/2008 | US20080138445 Pharmaceutical mixture for Hepatitis treatment and its preparation method |
| 06/12/2008 | US20080138442 Personal care method free of zinc pyrithione; basic zinc carbonate hydroxide, zinc copper carbonate, copper zinc carbonate hydroxide, phyllosilicate; anionic surfactant; skin, not scalp; treating microbial and fungal infections |
| 06/12/2008 | US20080138431 Microparticle; poly-lactide biodegradable polymer; polyuridylic acid immunogenic single-stranded ribonucleic acid; recombinant Protective Antigen of Bacillus anthracis biologically active macromolecule; cationic polymer or cationic lipid stabilizing agent; mucosal administration via inhaler; parenteral |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138385 2-mercaptopyridine-N-oxide sodium, carbendazim (methyl 1H-2-benzimidazole carbamate), or thiabendazole (2-(4-thiazolyl)-1H-benzimidazole); halogen-free; synergistic effect |
| 06/12/2008 | US20080138374 Molecular Plasma Deposition of Bioactive Small Molecules |
| 06/12/2008 | US20080138361 By virus-like proteins; transforming, culturing and isolating the recombinant yeast; immunotherapy of human papillomavirus-associated cancer |
| 06/12/2008 | US20080138360 A combined vaccine with immunization schedules that combine prime doses with DNA vaccine and booster doses either with proteins or recombinant viral vectors; chronic hepatitis C, cirrhosis and liver cancer |
| 06/12/2008 | US20080138359 Neisseria meningitidis lgtb Los as Adjuvant |
| 06/12/2008 | US20080138341 Anti-CD70 antibody and its use for the treatment of cancer and immune disorders |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138316 Use of a Combination of Cyclosporine and Pegylated Interferon for Treating Hepatitis C (Hcv) |
| 06/12/2008 | CA2671799A1 Cholesterylamines for the treatment and prevention of infectious diseases |
| 06/12/2008 | CA2671649A1 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors |
| 06/12/2008 | CA2671629A1 Vaccines including antigen from four strains of influenza virus |
| 06/12/2008 | CA2671317A1 Antiviral composition and method of use |
| 06/12/2008 | CA2670870A1 Antibacterial polycyclic urea compounds |
| 06/12/2008 | CA2670001A1 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 06/12/2008 | CA2669829A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2669819A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668558A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668520A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668517A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668515A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668512A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 06/11/2008 | EP1930407A1 Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 06/11/2008 | EP1930335A1 Cephalosporines having cyclic aminoguanidine substituents as Antibiotics |